Schlosser Mario: insider trades.
Schlosser Mario reported 10 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($25.3M), across 2 companies.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 2
- Name as filed
- Schlosser Mario
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Oscar Health, Inc. (OSCR) | Director | 9 |
| Duolingo, Inc. (DUOL) | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-03 | Oscar Health, Inc. | S | 31,422 | $31.45 | 449,444 | Form 4 |
| 2026-08-28 | Oscar Health, Inc. | C | 150,000 | — | 630,866 | Form 4 |
| 2026-08-28 | Oscar Health, Inc. | S | 150,000 | $30.79 | 480,866 | Form 4 |
| 2026-08-27 | Oscar Health, Inc. | C | 600,000 | — | 1,080,866 | Form 4 |
| 2026-08-27 | Oscar Health, Inc. | S | 600,000 | $30.34 | 480,866 | Form 4 |
| 2026-07-10 | Duolingo, Inc. | A | 140 | $124.76 | 4,262 | Form 4 |
| 2026-07-01 | Oscar Health, Inc. | C | 47,500 | — | 47,500 | Form 4 |
| 2026-07-01 | Oscar Health, Inc. | S | 3,600 | $29.5 | 43,900 | Form 4 |
| 2026-07-01 | Oscar Health, Inc. | S | 13,672 | $30.8 | 30,228 | Form 4 |
| 2026-07-01 | Oscar Health, Inc. | S | 30,228 | $31.65 | 0 | Form 4 |
Questions
What stock did Schlosser Mario buy or sell?
Schlosser Mario reported 10 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($25.3M), across 2 companies.
Is Schlosser Mario the same person as other filers with this name?
This page covers SEC CIK 1844320 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/schlosser-mario-1844320.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.